tiprankstipranks
Alzamend Neuro regains compliance with Nasdaq isting standards
PremiumThe FlyAlzamend Neuro regains compliance with Nasdaq isting standards
4M ago
Alzamend Neuro executed deal to provide sufficient capital for 18 months
Premium
The Fly
Alzamend Neuro executed deal to provide sufficient capital for 18 months
6M ago
Alzamend Neuro teams with MGH for lithium drug AL001 trial to treat PTSD
Premium
The Fly
Alzamend Neuro teams with MGH for lithium drug AL001 trial to treat PTSD
6M ago
Alzamend Neuro regains compliance with Nasdaq
PremiumThe FlyAlzamend Neuro regains compliance with Nasdaq
7M ago
Alzamend Neuro trading halted, news pending
Premium
The Fly
Alzamend Neuro trading halted, news pending
7M ago
Alzamend Neuro Announces Reverse Stock Split Decision
Premium
Company Announcements
Alzamend Neuro Announces Reverse Stock Split Decision
7M ago
Alzamend Neuro Unveils Updated Investor Presentation Outlook
PremiumCompany AnnouncementsAlzamend Neuro Unveils Updated Investor Presentation Outlook
9M ago
Alzamend Neuro Secures Strategic $25M Investment Deal
Premium
Company Announcements
Alzamend Neuro Secures Strategic $25M Investment Deal
10M ago
Alzamend Neuro announces registered direct offering
Premium
The Fly
Alzamend Neuro announces registered direct offering
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100